BioSpace News Archive

Patient Centered Medical Home Services Market: Growing adoption of patient centered medical home services is expected to drive the market

The global patient centered medical home services market is all set to grow at prodigious pace during the forecast period of 2020 to 2030.

January 27, 2021
·
4 min read
Radiation Proctitis Treatment Market: Sucralfate drugs sub-segment is likely to expand at a rapid pace during the forecast period

Radiation proctitis is inflammation and harm to the lower parts of the colon after X-ray or radiation treatment. Radiation treatment to the pelvis is critical in the treatment of pelvic malignancies, because it damage the DNA of the cancer cells and a result the proliferation stops.

January 27, 2021
·
4 min read
Cell Separation Market Growth is Drive by the Growing Interest of Biotechnology Companies in Stem Cell Research

The growth of the global cell separation market is estimated to be driven by the growing interest of scientists and biotechnology companies in stem cell research.

January 27, 2021
·
3 min read
Business

VarmX appoints Dr. Gerard Short as Chief Medical Officer

VarmX, a biotech company focusing on the development of innovative approaches for the reversal of anticoagulation, announces the appointment of Dr. Gerard Short, MBBS, as Chief Medical Officer.

January 27, 2021
·
3 min read
Genetron Health to Release Thirteen Research Findings at 21st World Conference on Lung Cancer

Genetron Holdings Limited announced that it will release thirteen new research findings at the 21st World Conference on Lung Cancer, which will be held virtually from January 28 to 31.

January 27, 2021
·
6 min read
Business

Itamar Medical Appoints Scott P. Serota to its Board of Directors

Itamar Medical Ltd., a leading medical device and digital health company focused on the integration of sleep apnea management into the cardiac patient care pathway, announced the appointment of Scott P. Serota to its Board of Directors.

January 27, 2021
·
2 min read
Drug Development

Ajinomoto Bio-Pharma Services and Humanigen Expand Manufacturing Agreement to Support Fill Finish for Investigational COVID-19 Therapeutic, Lenzilumab, Nearing Completion of Phase 3 Study - Jan 27, 2021

Ajinomoto Bio-Pharma Services and Humanigen, Inc. announced the companies will be expanding their manufacturing agreement for the fill finish supply of lenzilumab, which is one of the few Phase 3 treatment options in development for patients hospitalized with COVID-19.

January 27, 2021
·
6 min read
Theralase Launches Fourth Clinical Study Site in the US for Phase II Bladder Cancer Clinical Study

Theralase Technologies Inc.announced today that Carolina Urologic Research Center (“CURC”) has received site Institutional Review Board (“IRB”) approval to commence a Pivotal Phase II Non-Muscle Invasive Bladder Cancer (“NMIBC”) Clinical Study to enroll and treat patients with Bacillus Calmette Guerin(“BCG”)-Unresponsive Carcinoma In-Situ

January 27, 2021
·
4 min read
Bio NC

Heat Biologics Announces Publication of Additional Preclinical COVID-19 Vaccine Results

Heat Biologics, Inc.announces the publication of additional preclinical COVID-19 results in Frontiers in Immunology, a leading peer reviewed journal, which is available online.

January 27, 2021
·
4 min read
Drug Development

Immutep Announces Advancement Of Phase II Trial For Eftilagimod Alpha In Covid-19 Patients To Randomised Portion Of The Study

Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune disease, announced that an independent Data and Safety Monitoring Board (DSMB) has completed a safety run-in data review of the first six patients from the Phase II clinical trial of Eftilagimod Alpha Treatment by immune modulation in COVID-19 disease (EAT COVID),

January 27, 2021
·
4 min read